PT Medela Potentia, through its Argon Peduli initiative, reaffirms its commitment to advancing education, particularly in the healthcare sector, by presenting the prestigious Argon Award to the nation’s top pharmacy graduates. This year, the award was conferred upon outstanding graduates from two of Indonesia’s leading universities, University of Hasanuddin (Unhas), Makassar; and University of North Sumatera (USU), Medan.
The Argon Award was presented to apt. Noor Aisyah Harris, S. Farm from Universitas Hasanuddin and apt. Nurul Aini, S. Farm from Universitas Sumatera Utara. These recipients have been recognized for their exceptional academic achievements, strong dedication to pharmaceutical studies, and unwavering commitment to improving healthcare services and accessibility.
“Through Argon Peduli, we are proud to honor these two exemplary pharmacists from the University of Hasanuddin and the University of North Sumatera (USU), Medan with the Argon Award. This recognition reflects our long-standing commitment to supporting the next generation of pharmaceutical professionals who are instrumental in advancing healthcare in Indonesia,” said Mrs. Nancy Kartika, Human Resources Director of PT Medela Potentia.
The award was presented by Mrs. Endratri Retno Kiswati, Head of the AAM Medan Branch, and Mr. Ipung Wahyu Wibowo, Head of the AAM Makassar Branch, during the Pharmacist Oath/Promise Ceremonies at USU on Saturday, September 21, 2024, and Unhas on Monday, September 24, 2024.
As a company with over four decades of experience, PT Medela Potentia and its subsidiaries are committed to enhancing the quality of education and fostering the professional growth of healthcare practitioners. Through the Argon Award, the company seeks to inspire pharmacy students to continue innovating, contributing, and delivering optimal healthcare solutions for the community.
The Argon Award is a key component of Medela Potentia’s vision to strengthen collaborations with leading educational institutions across Indonesia. PT Medela Potentia remains optimistic about supporting the achievement of the United Nations Sustainable Development Goals and shaping the future of the pharmaceutical industry, while enhancing access to healthcare products nationwide.